Should we expect a wave of type 1 diabetes following SARS-CoV-2 pandemic?

Diabetes Metab Res Rev. 2022 May;38(4):e3529. doi: 10.1002/dmrr.3529.
No abstract available

Keywords: COVID-19; beta-cell damage; pancreatic autoimmunity; type 1 diabetes.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / epidemiology
  • Diabetes Mellitus, Type 1* / epidemiology
  • Humans
  • Pandemics
  • SARS-CoV-2